Related by context. Frequent words. (Click for all words.) 70 Meets Primary Endpoint 66 Benign Prostatic Hyperplasia 66 Initiates Phase II 66 Cetrorelix 66 Carfilzomib 66 Eculizumab 65 Clinical Trial Results 65 Microspheres 65 Patient Enrollment 65 Pirfenidone 65 Hepatocellular Carcinoma 64 Bone Graft 64 Receives Orphan Drug Designation 64 Completes Enrollment 64 Tesetaxel 64 inhaled formulation 64 FDA Accepts 64 Phase III Clinical Trial 63 fibrosis IPF 63 J Am Coll 63 Myelofibrosis 63 Golimumab 63 Inflammatory Diseases 63 liposomal formulation 63 VALSTAR 63 Genaera Corporation 63 Pluristem Therapeutics 63 FzioMed 63 Entereg R 63 Microplasmin 63 Lubiprostone 63 Single Dose 63 proteasome inhibitor 63 secondary hyperparathyroidism 63 Pivotal Phase III 63 Ambrisentan 63 gastrointestinal stromal tumors GIST 63 Factor VIIa 62 Atopic Dermatitis 62 Inc Therapeutic Competitors 62 DDP# 62 Commences Phase 62 Harbor BioSciences 62 Diabetic Macular Edema 62 Pivotal Trial 62 VIA Pharmaceuticals 62 Regado Biosciences 62 Transcept Pharmaceuticals 62 MKC# 62 RNAi Therapeutics 62 TELINTRA 62 mesylate 62 Drug Candidate 62 Panzem R 62 Metastatic Melanoma 61 Mucosal 61 Presents Positive 61 pseudobulbar affect PBA 61 Recombinant Human 61 Octreotide 61 diabetic macular edema DME 61 Mipomersen 61 Locteron ® 61 Pivotal Phase 61 Kuvan R 61 Preclinical Data 61 Epratuzumab 61 Pulmonary Arterial Hypertension 61 Celsion Corporation 61 Chronic Heart Failure 61 Onychomycosis 61 Overactive Bladder 61 Amphotericin B 61 Anti Infectives 61 Announces FDA Clearance 61 Chemokine Therapeutics 61 topical anti infective 61 Aloxi R 61 Allergic Rhinitis 61 AEG# 61 Surgical Adhesive 60 Anika Therapeutics 60 NovaBay Pharmaceuticals 60 J Am Acad 60 Mucositis 60 Proxinium TM 60 Amgen discovers develops 60 Levulan R 60 CardioVascular BioTherapeutics Inc. 60 Testim R 60 PARI Pharma 60 FDA Clears 60 Aradigm Corporation 60 Milnacipran 60 post herpetic neuralgia PHN 60 Ferumoxytol 60 Fenofibrate 60 immunologic diseases 60 MultiCell Technologies 60 ThermoDox R 60 teriflunomide